Number of the records: 1  

Continuous intrajejunal levodopa-carbidopa intestinal gel in the treatment of patients with advanced Parkinson’s disease – effects on motor symptoms

  1. SYS0173841
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20210716115220.1
    100
      
    $a 20210716d2015 m y0sloy0103 ba
    101
    0-
    $a eng
    102
      
    $a SK
    200
    1-
    $a Continuous intrajejunal levodopa-carbidopa intestinal gel in the treatment of patients with advanced Parkinson’s disease – effects on motor symptoms $f Gmitterová K., Minár M., Smutný M. ... et al.
    303
      
    $a Popis urobený z citácie
    463
    -1
    $1 200 1 $a Activitas Nervosa Superior REDIVIVA $v Vol. 57, no. 3 (2015), s. 57-62
    701
    -1
    $3 sllk_un_auth*p0045987 $a Gmitterová $b Karin $p 2. neurologická klinika LU FK a UN, Bratislava $4 070
    701
    -1
    $3 sllk_un_auth*0024052 $a Minár $b Michal $p 2. neurologická klinika LF UK a UNB, Bratislava $4 070
    701
    -1
    $3 sllk_un_auth*p0046628 $a Smutný $b Milan $p III. interná klinika LF UK, FN L. Dérera, Bratislava $4 070
    801
    -0
    $a SK $b BA006 $c 20210716 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.